FGFR2 and breast cancer: The estimated increases in the risk of BRCAX or high-risk breast cancers from the variants on FGFR2, TOX3, and ESR1 were quite similar across populations (ORs for highest compared to lowest tertile = 2.2 to 2.4, Fig. 2B).